|
- The New Stakeholder Economics of Part D After the IRA
On January 1, 2025, the Inflation Reduction Act (IRA)’s Medicare Part D redesign provisions went into effect for all Part D drugs These provisions lower the beneficiary out-of-pocket (OOP) cap and increase plan and manufacturer liability, particularly in the catastrophic phase of coverage
- The IRA in 2025: The Future of Medicare Part D | Mintz
The IRA’s redesign of Part D includes a government subsidy program for Selected Drugs, pursuant to which PDPs will receive a 10% subsidy to reduce their liability for Selected Drugs
- The IRA’s Unintended Consequences for Drug Pricing and Coverage
Experts warn of potential unintended consequences, including reduced rebate flexibility and non-medical switching, impacting patient access and affordability The IRA's impact on 340B-covered
- Keeping watch on the Inflation Reduction Act: Medicare poses Part D . . .
We evaluated Medicare Part D formulary access for a selection of drugs in March 2025 We compared the Part D formulary access in March 2025 to that in 2024 Our evaluation encompasses drugs from a range of therapeutic classes, each with varying costs to Medicare and beneficiaries
- Subtler scopes: Where IRA drug negotiations meet Part D redesigns . . .
Specifically, the new Part D Manufacturer Discount Program for 2025 requires the manufacturer to provide a 10% discount on branded drugs after a patient reaches their deductible The discount is increased to 20% following a $2,000 OOP patient spend with no upper threshold
- Final CY 2026 Part D Redesign Program Instructions
These Final CY 2026 Program Instructions also provide interested parties with final guidance on the successor regulation exception to the IRA’s formulary inclusion requirement for selected drugs, a topic relevant to the Medicare Part D program that relates to the implementation of sections 11001 and 11002 of the IRA, which establish the Medicare
- Part D redesign under the Inflation Reduction Act - Milliman
While it may be hard to imagine Medicare without drug coverage today, Medicare did not cover prescription drugs for most beneficiaries during its first 50 years The Medicare Modernization Act (MMA), passed in 2003, created the Medicare Part D program
- Overview of Inflation Reduction Act 2025 Medicare Part D Redesign
Under the Medicare Discount Program (which conceptually replaces the Coverage Gap Discount Program), Part D drugs dispensed to beneficiaries will be subject to manufacturer discounts during
|
|
|